Early diagnosis needed to improve outcomes in IBS
NEW YORK — In this exclusive video, Aimee Lenar, Allergan’s Vice President of GI Marketing, discusses the importance of educating clinicians, particularly primary care physicians, on the importance of early diagnosis for improving outcomes for the nearly 60 million Americans with irritable bowel syndrome or chronic idiopathic constipation.
“Unfortunately, many of these patients are not diagnosed,” Lenar told Healio Gastroenterology and Liver Disease. “Primary care physicians can diagnose IBS, and they can do it quickly in an office with some very easy guidelines in the absence of alarm features, and by diagnosing IBS earlier, it leads to greater patient satisfaction and ultimately better outcomes.”
Disclosures: Lenar is employed by Allergan.